digital currency group subsidiary- Top snippets

Guosheng Financial Holdings recently announced that the company has received the "Acceptance Form for Administrative License Application of China Securities Regulatory Commission" issued by China Securities Regulatory Commission, and the CSRC has accepted the application for administrative license for the merger of Guosheng Securities by Guosheng Financial Holdings. The merger and acquisition still needs the approval of the CSRC, and there are uncertainties about whether and when the relevant approval can be obtained and the final implementation completion time. The company will disclose the progress in a timely manner in accordance with relevant regulations.As for the market outlook of the brokerage sector, Guojin Securities said that in 2025, liquidity is expected to be further relaxed, which will improve the stability of the market, the improvement of economic fundamentals will be confirmed, and the stock market is expected to rise further, which will benefit the valuation and performance of the brokerage sector.

A shares fluctuated higher, and the large consumer sector collectively strengthened.The big financial sector, led by brokers, pulled up before noon yesterday, boosting the index further. At the close, Guosheng Financial Holdings and Guolian Securities had daily limit, while Harbin Investment and Southwest Securities rose more than 5%.

Ice and snow economy concept stocks have been active recently and strengthened again yesterday. At the close, Jingxue Energy Saving had a daily limit of 20%, Dalian Shengya, Yingpaisi and Iceberg had daily limit, and Changbai Mountain and Sanfu Outdoor rose by over 5%.On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.Guolian Securities recently announced that the M&A Review Committee of Shanghai Stock Exchange is scheduled to hold the 6th M&A Review Committee review meeting in 2024 on December 17th to review the company's application for this transaction.